← Back
Data updated: Mar 10, 2026
CATALENT
Immunology
CATALENT is a generic drug manufacturer focused on Immunology.
1991
Since
3
Drugs
-
Trials
26
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CETIRIZINE HYDROCHLORIDE ALLERGY 2026-01-30
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-15
Labeling
NAPROXEN SODIUM 2025-09-16
Labeling
NAPROXEN SODIUM 2025-09-16
Labeling
NAPROXEN SODIUM 2025-09-16
Labeling
NAPROXEN SODIUM 2025-09-16
Labeling
NAPROXEN SODIUM 2025-08-28
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (2)
Company Info
- First Approval
- 1991-10-29
- Latest
- 2023-09-19
- Applications
- 3